Onderzoeker
Quentin Lecocq
- Onderzoeksexpertise:
Expertise: Tumor immunology.
We evaluate the use of single domain antibodies (sdAbs), also known as nanobodies, as targeting moieties for therapeutic and diagnostic applications.
- Trefwoorden:Geneeskunde
- Disciplines:Medische en gezondheidswetenschappen, Sociale wetenschappen
- Gebruikers van onderzoeksexpertise:
Expertise: Tumor immunology.
We evaluate the use of single domain antibodies (sdAbs), also known as nanobodies, as targeting moieties for therapeutic and diagnostic applications.
Affiliaties
- Laboratorium voor Moleculaire en Cellulaire Therapie (Onderzoeksgroep)
Lid
Vanaf19 mrt 2021 → Heden - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 jan 2018 → 31 dec 2021 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 okt 2016 → 30 sep 2021 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf18 aug 2016 → 23 nov 2021 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf31 aug 2014 → 21 jun 2016
Projecten
1 - 1 of 1
- Nanobody gemedieerde beeldvorming en blokkering van de inhiberende receptor LAG-3Vanaf1 jan 2018 → 31 dec 2021Financiering: FWO mandaten
Publicaties
11 - 20 van 20
- Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.(2020)
Auteurs: Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, Dominic Maertens, Mireille Gysemans, Tony Lahoutte, Catarina Xavier, Quentin Lecocq, Ken Maes, Peter Covens, et al.
Pagina's: 3553-3566 - Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies(2020)
Auteurs: Janik Puttemans, Yana Dekempeneer, Jos Leon Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Karine Breckpot, Quentin Lecocq, Tony Lahoutte, Albert D Windhorst, et al.
- Theranostics in immuno-oncology using nanobody derivatives(2019)
Auteurs: Quentin Lecocq, Y De Vlaeminck, Heleen Hanssens, Matthias D'Huyvetter, Geert Raes, C Goyvaerts, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot
Pagina's: 7772-7791 - Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use(2019)
Auteurs: Quentin Lecocq, Katty Zeven, Y De Vlaeminck, Sandrina Martens, Sam Massa, C Goyvaerts, Geert Raes, Marleen Keyaerts, Karine Breckpot, Nick Devoogdt
- Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production(2019)
Auteurs: Katrijn Broos, Quentin Lecocq, Brenda De Keersmaecker, Geert Raes, Jurgen Corthals, Eva Lion, Kris Thielemans, Nick Devoogdt, Marleen Keyaerts, Karine Breckpot
Pagina's: E85-E85 - Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent(2019)
Auteurs: Katrijn Broos, Quentin Lecocq, Catarina Xavier, Jessica Bridoux, Tham Nguyen, Jurgen Corthals, Steve Joël Marie-José Schoonooghe, Eva Lion, Geert Raes, Marleen Keyaerts, et al.
- Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages(2019)
Auteurs: Y De Vlaeminck, Quentin Lecocq, Philippe Giron, Xenia Geeraerts, Steve Schoonooghe, Kiavash Movahedi, Sam Massa, Evangelia Bolli, C Goyvaerts, Jo A Van Ginderachter, et al.
Pagina's: 107-120 - A versatile T cell-based assay to assess therapeutic antigenspecific PD-1-targeted approaches(2018)
Auteurs: Maarten Versteven, Johan M.J. Van den Bergh, Katrijn Broos, Fumihiro Fujiki, Diana Campillo-Davo, Hans De Reu, Soyoko Morimoto, Quentin Lecocq, Marleen Keyaerts, Zwi Berneman, et al.
Pagina's: 27797-27808 - Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy(2018)
Auteurs: Katrijn Broos, Quentin Lecocq, Geert Raes, Nick Devoogdt, Marleen Keyaerts, Karine Breckpot
Pagina's: 3559-3570 - Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers(2017)
Auteurs: Katrijn Broos, Marleen Keyaerts, Quentin Lecocq, Dries Renmans, Nguyen T., D. Escors, Liston A., Geert Raes, Karine Breckpot, Nick Devoogdt
Pagina's: 41932-41946
Patenten
1 - 2 van 2
- Anti lag3 vhhs and their use (Inventor)
- Anti lag3 vhhs and their use (Inventor)